TD SYNNEX (NYSE: SNX) director executes 10b5-1 option exercises and share sales

Rhea-AI Filing Summary

TD SYNNEX director Richard T. Hume reported planned option exercises and share sales in SNX stock. On January 28 and 29, 2026, he exercised employee stock options at $107.32 per share to acquire 12,991 and 25,000 shares of common stock, respectively. He then sold blocks of 12,745, 246, 18,080, and 6,920 shares at weighted average prices between $160.00 and about $161.52, as detailed in the footnotes. These trades were carried out under a Rule 10b5-1 trading plan adopted on July 14, 2025. After the transactions, he directly owned 47,515 shares of TD SYNNEX common stock and retained fully vested stock options covering additional shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUME RICHARD T

(Last) (First) (Middle)

5350 TECH DATA DRIVE

(Street)

CLEARWATER FL 33760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		M(1)		12,991	A	$107.32	60,506	D
Common Stock	01/28/2026		S(1)		12,745	D	$160.32(2)	47,761	D
Common Stock	01/28/2026		S(1)		246	D	$161.15(3)	47,515	D
Common Stock	01/29/2026		M(1)		25,000	A	$107.32	72,515	D
Common Stock	01/29/2026		S(1)		18,080	D	$160.5(4)	54,435	D
Common Stock	01/29/2026		S(1)		6,920	D	$161.12(5)	47,515	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$107.32	01/28/2026		M(1)			12,991	(6)	10/05/2031	Common Stock	12,991	$0	43,857	D
Employee Stock Option (Right to Buy)	$107.32	01/29/2026		M(1)			25,000	(6)	10/05/2031	Common Stock	25,000	$0	18,857	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.955. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.02 to $161.50. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

4. Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

5. Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.00 to $161.52. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

6. This stock option is fully vested.

Remarks:

	/s/ Cheryl Grant, attorney-in-fact	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did TD SYNNEX (SNX) director Richard T. Hume report?

Richard T. Hume reported exercising employee stock options and selling TD SYNNEX (SNX) shares. On January 28–29, 2026, he exercised options at $107.32 per share and sold several share blocks at weighted average prices around $160–$161 under a Rule 10b5-1 plan.

How many TD SYNNEX (SNX) options did Richard Hume exercise in this Form 4?

Richard Hume exercised 12,991 employee stock options on January 28, 2026, and 25,000 options on January 29, 2026. Both sets of options had a $107.32 exercise price and were fully vested, resulting in the acquisition of an equal number of TD SYNNEX (SNX) common shares.

At what prices did Richard Hume sell TD SYNNEX (SNX) shares?

Hume’s TD SYNNEX (SNX) share sales used weighted average prices. Reported averages were $160.32, $161.15, $160.50, and $161.12 per share, with underlying individual trades occurring in price ranges from $160.00 up to $161.52, as described in the footnotes.

How many TD SYNNEX (SNX) shares does Richard Hume own after these transactions?

After the reported transactions, Richard Hume directly owned 47,515 TD SYNNEX (SNX) common shares. He also continued to hold employee stock options, which remained fully vested and exercisable for additional shares as shown in the derivative securities table.

Were Richard Hume’s TD SYNNEX (SNX) trades made under a Rule 10b5-1 plan?

Yes. The Form 4 states the option exercises and related share sales were effected under a Rule 10b5-1 trading plan. This plan was adopted by Richard Hume on July 14, 2025, and governed the January 2026 transactions in TD SYNNEX (SNX) stock.

What do the weighted average prices mean in Richard Hume’s SNX share sales?

Weighted average prices summarize multiple TD SYNNEX (SNX) trades executed within stated ranges, such as $160.00–$160.955. The filing notes Hume will provide details on the number of shares sold at each specific price within those ranges upon request.